Learning Objectives:

1. Summarize the association between rheumatoid arthritis (RA) and cancer.

2. Appraise the literature regarding association between use of DMARDs and the risk of cancer in RA.

3. Discuss outcomes of patients with pre-existing RA who develop cancer adjusted for frailty status.

4. Very briefly discuss the latest data on immunotherapy related inflammatory arthritis (ICI-IA).

 

 

Session date: 
04/16/2024 - 8:30am to 9:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Nimrata Singh, MD, MSCI